Predictors of Early and Sustained Response to Infliximab in Patients with Ulcerative Colitis

被引：0
|
作者：
Rostholder, Emily [1 ]
Ahmed, Awais [1 ]
Moss, Alan [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-01204
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1204
引用
收藏
页码：S440 / S440
页数：1
相关论文
共 50 条
  • [1] Predictors of early response to infliximab in patients with ulcerative colitis
    Ferrante, Marc
    Vermeire, Severine
    Katsanos, Konstantinos H.
    Noman, Maja
    Van Assche, Gert
    Schnitzler, Fabian
    Arijs, Ingrid
    De Hertogh, Gert
    Hoffman, Ilse
    Geboes, Karel
    Rutgeerts, Paul
    [J]. INFLAMMATORY BOWEL DISEASES, 2007, 13 (02) : 123 - 128
  • [2] Predictors of early clinical response to infliximab in 100 patients with ulcerative colitis
    Ferrante, M.
    Vemeire, S.
    Katsanos, K. H.
    Noman, M.
    Van Assche, C.
    De Hertogh, G.
    Hoffman, I.
    Geboes, K.
    Rutgeerts, P.
    [J]. ACTA CLINICA BELGICA, 2006, 61 (05): : 299 - 299
  • [3] Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical Response
    Bortlik, Martin
    Duricova, Dana
    Malickova, Karin
    Machkova, Nadezda
    Komarek, Viktor
    Bouzkova, Eva
    Lukas, Milan
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S591 - S592
  • [4] Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Sandborn, William J.
    Armuzzi, Alessandro
    Liguori, Giuseppina
    Irving, Peter M.
    Sharara, Ala, I
    Mundayat, Rajiv
    Lawendy, Nervin
    Woolcott, John C.
    Danese, Silvio
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 (09) : 1338 - 1347
  • [5] Predictors of Infliximab Failure in Ulcerative Colitis
    Stein, Daniel
    Behm, Brian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S505 - S505
  • [6] Predictors of bad response to infliximab in Ulcerative Colitis patients (ECIA study. ACAD)
    Fernandez-Salazar, L.
    Fernandez, N.
    Sanchez-Ocana, R.
    Joao, D.
    Santos, F.
    Bouhmidi, A.
    Legido, J.
    Prieto, V.
    Rivero, M.
    Pajares, R.
    Munoz, C.
    Herranz, M.
    Macho, A.
    Barrio, J.
    Munoz, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S330 - S330
  • [7] BOWEL ULTRASOUND AND FAECAL CALPROTECTIN AS PREDICTORS OF RESPONSE TO INFLIXIMAB IN ULCERATIVE COLITIS
    Bezzio, C.
    Furfaro, F.
    Carmagnola, S.
    Maconi, G.
    Manes, G.
    Saibeni, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 : E207 - E207
  • [8] Neutrophil-to-lymphocyte ration in ulcerative colitis predicts sustained response to infliximab
    Nishida, Y.
    Hosomi, S.
    Watanabe, K.
    Yukawa, T.
    Otani, K.
    Nagami, Y.
    Tanaka, F.
    Taira, K.
    Kamata, N.
    Shiba, M.
    Yamagami, H.
    Tanigawa, T.
    Watanabe, T.
    Tominaga, K.
    Fujiwara, Y.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S294 - S294
  • [9] Predictors of Response to Infliximab As Salvage Therapy for Severe Steroid Refractory Ulcerative Colitis
    Vaughn, Byron P.
    Pleet, Julie
    Cheifetz, Adam S.
    Moss, Alan C.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S434 - S434
  • [10] Adalimumab for Ulcerative Colitis Patients Previously Treated With Infliximab: Outcomes at Short and Long Term and Predictors of Response
    Taxonera, Carlos
    Estelles, Jesus
    Blanco, Ignacio
    Merino, Olga
    Marin-Jimenez, Ignacio
    Barreiro, Manuel
    Saro, Cristina
    Garcia, Valle
    Gento, Elena
    Bastida, Guillermo
    Gisbert, Javier P.
    Vera, Isabel
    Martinez, Pilar
    Mendoza, Juan L.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S61 - S61
12345